TOP
Nav Bar
  1. General Info
  2. Effects Info
  3. Reference
Drug Interaction Details
01. General Information
Pair Name Jervine, Decitabine
Phytochemical Name Jervine (PubChem CID: 10098 )
Anticancer drug Name Decitabine (PubChem CID: 451668 )
Structure of
Phytochemical
2D-img
Download
2D MOL 3D MOL
Structure of
Anticancer Drug
2D-img
Download
2D MOL 3D MOL
02. Combinatorial Therapeutic Effect(s)
Synergistic Effect
Hide/Show
Enhancing Drug Efficacy
Hide/Show
Combination Pair ID: 48
Pair Name Jervine, Decitabine
Disease Info [ICD-11: 2A3Z] Myelodysplastic syndrome Investigative
Biological Phenomena Induction-->Apoptosis
Gene Regulation Down-regulation Expression AKT1 hsa207
Down-regulation Expression BCL2 hsa596
Up-regulation Expression CASP3 hsa836
Down-regulation Expression CCND1 hsa595
Down-regulation Expression Gli1 hsa2735
Down-regulation Expression PIK3CA hsa5290
Down-regulation Expression SMO hsa6608
In Vitro Model MUTZ-1 EBV-related Burkitt lymphoma Homo sapiens (Human) CVCL_1431
Result The Smo inhibitor jervine and its combination with decitabine have a synergistic effect on the proliferation, cell cycle, and apoptosis of MUTZ-1 cells, and its mechanism may be achieved by interfering with the Shh signaling pathway.
03. Reference
No. Title Href
1 Synergistic inhibitory effect of Smo inhibitor jervine and its combination with decitabine can target Hedgehog signaling pathway to inhibit myelodysplastic syndrome cell line. Hematology. 2021 Dec;26(1):518-528. doi: 10.1080/16078454.2021.1950897. Click
It has been 46509 visits since 2024.08
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang
TOP